Annelies C. Wauters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Annelies C. Wauters has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Jan C. M. van Hest
Bio-Organic Chemistry, Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands
3 shared publications - Loai K. E. A. Abdelmohsen
Eindhoven University of Technology
3 shared publications - Alexander Francesco Mason
Molecular Horizons and School of Science, Faculty of Science, Medicine and Health, University of Wollongong, New South Wales, 2522, Australia
2 shared publications - Jari F. Scheerstra
Bio-Organic Chemistry, Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands
2 shared publications - Abraham Jozef Petrus Teunissen
BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
1 shared publication - Anja R. A. Palmans
Department of Chemical Engineering & Chemistry and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 31 July 2024
- Published by Springer Nature in Nature Nanotechnology
- Vol. 19 (11) , 1735-1744
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy
Regulating innate immunity is an emerging approach to improve cancer immunotherapy. Such regulation requires engaging myeloid cells by delivering immunomodulatory compounds to hematopoietic organs, including the spleen. Here we present a polymersome-based nanocarrier with splenic avidity and propensity for red pulp myeloid cell uptake. We characterized the in vivo behaviour of four chemically identical yet topologically different polymersomes by in vivo positron emission tomography imaging and innovative flow and mass cytometry techniques. Upon intravenous administration, relatively large and spherical polymersomes accumulated rapidly in the spleen and efficiently targeted myeloid cells in the splenic red pulp. When loaded with β-glucan, intravenously administered polymersomes significantly reduced tumour growth in a mouse melanoma model. We initiated our nanotherapeutic’s clinical translation with a biodistribution study in non-human primates, which revealed that the platform’s splenic avidity is preserved across species.
- 31 July 2024
- Published by Springer Nature in Nature Nanotechnology
- Vol. 19 (11) , 1735-1744
Open AccessPolymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy
Regulating innate immunity is an emerging approach to improve cancer immunotherapy. Such regulation requires engaging myeloid cells by delivering immunomodulatory compounds to hematopoietic organs, including the spleen. Here we present a polymersome-based nanocarrier with splenic avidity and propensity for red pulp myeloid cell uptake. We characterized the in vivo behaviour of four chemically identical yet topologically different polymersomes by in vivo positron emission tomography imaging and innovative flow and mass cytometry techniques. Upon intravenous administration, relatively large and spherical polymersomes accumulated rapidly in the spleen and efficiently targeted myeloid cells in the splenic red pulp. When loaded with β-glucan, intravenously administered polymersomes significantly reduced tumour growth in a mouse melanoma model. We initiated our nanotherapeutic’s clinical translation with a biodistribution study in non-human primates, which revealed that the platform’s splenic avidity is preserved across species.
- Open Access
- 1 March 2022
- Published by Elsevier in Materials Today Advances
- Vol. 13
Polymersomes as a potential platform for cancer immunotherapy
- 1 March 2022
- Published by Elsevier in Materials Today Advances
- Vol. 13
Open AccessPolymersomes as a potential platform for cancer immunotherapy
- Open Access
- 28 September 2018
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 20 (1) , 177-183
Development of Morphologically Discrete PEG–PDLLA Nanotubes for Precision Nanomedicine
Precise control over the morphological features of nanoparticles is an important requisite for their application in nanomedical research. Parameters such as size and shape have been identified as critical features for effective nanotherapeutic technologies due to their role in circulation, distribution and internalization in vivo. Tubular PEG-PDLLA polymersomes (nanotubes) exhibit an interesting morphology with potential for immunotherapeutics, as the elongated shape can affect cell-particle interactions. Developing methodologies that permit control over the precise form of such nanotubes is important for their biomedical implementation due to the stringent physicochemical constraints for efficacious performance. Through careful control over the engineering process, we demonstrate the generation of well-defined nanotubes based upon polymersomes as small as 250 and 100 nm, which can be successfully shape transformed. The quality of the resulting nanostructures was established by physical characterization using AF4-MALS and cryo-TEM. Moreover, we show the successful loading of such nanotubes with model payloads (proteins and drugs). These findings provide a promising platform for implementation in biomedical applications in which discrete structure and functionality are essential features.
- 28 September 2018
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 20 (1) , 177-183
Open AccessDevelopment of Morphologically Discrete PEG–PDLLA Nanotubes for Precision Nanomedicine
Precise control over the morphological features of nanoparticles is an important requisite for their application in nanomedical research. Parameters such as size and shape have been identified as critical features for effective nanotherapeutic technologies due to their role in circulation, distribution and internalization in vivo. Tubular PEG-PDLLA polymersomes (nanotubes) exhibit an interesting morphology with potential for immunotherapeutics, as the elongated shape can affect cell-particle interactions. Developing methodologies that permit control over the precise form of such nanotubes is important for their biomedical implementation due to the stringent physicochemical constraints for efficacious performance. Through careful control over the engineering process, we demonstrate the generation of well-defined nanotubes based upon polymersomes as small as 250 and 100 nm, which can be successfully shape transformed. The quality of the resulting nanostructures was established by physical characterization using AF4-MALS and cryo-TEM. Moreover, we show the successful loading of such nanotubes with model payloads (proteins and drugs). These findings provide a promising platform for implementation in biomedical applications in which discrete structure and functionality are essential features.
- Open Access
- 8 December 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 7 (3) , 2011-2015
Surface water retardation around single-chain polymeric nanoparticles: critical for catalytic function?
A library of water-soluble dynamic single-chain polymeric nanoparticles (SCPN) was prepared using a controlled radical polymerisation technique followed by the introduction of functional groups, including probes at targeted positions.
- 8 December 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 7 (3) , 2011-2015
Open AccessSurface water retardation around single-chain polymeric nanoparticles: critical for catalytic function?
A library of water-soluble dynamic single-chain polymeric nanoparticles (SCPN) was prepared using a controlled radical polymerisation technique followed by the introduction of functional groups, including probes at targeted positions.